Table 2.

Glucose variability during the study in the whole group and depending on HbA₁c improvement.

		Study group	HbA1c improvement	No HbA1c improvement
HbA1c (%)	Before the study After the study p	9.35 ± 1.5 8.81 ± 1.8 <0.001	9.03 ± 1.35 8.04 ± 1.33∗  <0.001	10.03 ± 1.71  10.42 ± 1.60∗  0.102
Mean glucose (mg/dL)	1st week Last week p	168.18 ± 33.9 144.8 ± 22.9 <0.001	164.44 ± 37 138.22 ± 31∗  <0.001	175.92 ± 22.77 158.46 ± 21.19∗  <0.001
Mean glucose SD (mg/dL)	1st week Last week p	61.25 ± 14.5 53.55 ± 14.1 0.002	60.74 ± 15 51.67 ± 14 0.010	62.31 ± 12.43 57.46 ± 21.19 0.050
AUC > 140 mg/dL	1st week Last week p	43.29 ± 26.1 25.23 ± 16.9 <0.001	41.23 ± 29 21.22 ± 15∗  <0.001	47.56 ± 18.47 33.58 ± 17.41∗  <0.001
AUC < 70 mg/dL	1st week Last week p	0.58 ± 0.61 0.53 ± 0.53 0.591	0.73 ± 0.6∗  0.62 ± 0.5 0.439	0.29 ± 0.36∗  0.35 ± 0.36 0.576
Max glucose (mg/dL)	1st week Last week p	365.15 ± 74.5 328.6 ± 67.2 0.002	344.37 ± 57 317.41 ± 55 0.004	380.6 ± 100.08 354.92 ± 82.98 <0.001
Min glucose (mg/dL)	1st week Last week p	51.15 ± 12.5 47.5 ± 6.4 0.045	49.85 ± 13 46.07 ± 5∗  0.136	53.85 ± 10.05 50.46 ± 7.31∗  0.107
FMD (%)	Before the study After the study p	10.9 ± 6.6 16.67 ± 8.5 <0.001	12.22 ± 5.41 19.27 ± 7.40∗  <0.001	8.18 ± 8.15 11.29 ± 8.35∗  0.089

Results of RT-CGM are presented as mean ± SD.

^∗ p < 0.05: significant difference between two subgroups, considering the same time sensor usage (first or last week).